AdaptHealth Corp Dossier
Outlook & Key Dates
Estimates, guidance, catalysts, and upcoming events
Analyst Estimates Learn more →
5-Yr Fwd EPS Growth
-9.9%projected annual EPS growth
Analyst Coverage
7analysts covering
Reporting Calendar
| Event | Expected Date |
|---|---|
| Q3 2026 Earnings Release | 6 Nov 2026 |
Monitoring Framework
Key Performance Indicators
Net Revenue Quarterly3.2BTarget: 3.45 billion to 3.52 billion
Adjusted EBITDA Quarterly616.7MTarget: 680 million to 730 million
Free Cash Flow Quarterly219.4MTarget: 175 million to 225 million
Registered myApp Users Quarterly412KTarget: Continued digital portal expansion
Watch Items
- Capitated Contract Labor CostsTrigger: Elevated transition labor costs impacting Adjusted EBITDA marginsAction: Monitor management's cost-moderation steps and margin normalization starting in Q2 2026
- Debt Leverage and Refinancing ExecutionTrigger: Redemption of 6.125% Senior Notes due 2028 after call premium expiration in August 2026Action: Verify complete redemption using committed capital from the April 2026 credit facility refinancing
- Reimbursement and Regulatory PressuresTrigger: Unilateral payor rate cuts or unfavorable DMEPOS bidding outcomesAction: Assess impact on gross margins and evaluate market share gains from exiting smaller players
Research as of 20 Jun 2026